These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7048879)

  • 1. Effects of pindolol and methyldopa on blood pressure and plasma norepinephrine.
    Winer N; Carter CH; Eddy H
    Am Heart J; 1982 Aug; 104(2 Pt 2):425-31. PubMed ID: 7048879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pindolol: effects on blood pressure and plasma renin activity.
    Glassock RJ; Weitzman RE; Bennett CM; Maxwell M; Hamilton B; Winer N; Kirkendall W; Gonasun L
    Am Heart J; 1982 Aug; 104(2 Pt 2):421-5. PubMed ID: 7048878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of trimazosin and methyldopa in hypertension.
    Aronow WS; Tobis J; Hughes D; Siegel J; Easthope J
    Clin Pharmacol Ther; 1977 Oct; 22(4):425-9. PubMed ID: 332438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The combination of methyldopa with pindolol in the treatment of hypertension (author's transl)].
    Szám I; Pálossy B
    MMW Munch Med Wochenschr; 1978 Dec; 120(51-52):1719-22. PubMed ID: 105251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of Visken to methyldopa therapy in hypertension: a multicentre study.
    Murphy JE
    J Int Med Res; 1976; 4(2):128-31. PubMed ID: 1026542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of pregnancy-induced hypertension with pindolol--comparative study with methyldopa.
    Ellenbogen A; Jaschevatzky O; Davidson A; Anderman S; Grunstein S
    Int J Gynaecol Obstet; 1986 Feb; 24(1):3-7. PubMed ID: 2874067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacy and safety of pindolol and alpha-methyldopa in treatment of mild to moderate hypertension: results of a double-blind evaluative study.
    Beanlands DS; Allard PP; Wilson M; Orbeck KW; Helman AB; Lefebvre R
    Clin Invest Med; 1978; 1(3-4):139-45. PubMed ID: 391453
    [No Abstract]   [Full Text] [Related]  

  • 8. Methyldopa combined with prindolol in the treatment of severe hypertension.
    Seedat YK
    S Afr Med J; 1974 Aug; 48(38):1608-10. PubMed ID: 4615382
    [No Abstract]   [Full Text] [Related]  

  • 9. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
    Hartikainen M; Heikkilä J
    Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension.
    Luomanmäki K; Hartikainen M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S63-7. PubMed ID: 2423800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.
    Struthers AD; Brown MJ; Adams EF; Dollery CT
    Br J Clin Pharmacol; 1985 Mar; 19(3):311-7. PubMed ID: 3986086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.
    Brecht HM; Banthien F; Schoeppe W
    Klin Wochenschr; 1976 Nov; 54(22):1095-105. PubMed ID: 1003867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative antihypertensive effects of guanabenz and methyldopa.
    Walker BR; Deitch MW; Schneider BE; Hare LE
    Clin Ther; 1981; 4(4):275-84. PubMed ID: 7332915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol.
    Hansson L; Dahlof B
    Am J Cardiol; 1987 Jan; 59(3):137B-140B. PubMed ID: 2949584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood pressure and renin activity in essential hypertension under pindolol].
    Nussberger J; Vetter W; Furrer J; Beckerhoff R; Würsten D; Schmied U; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Jun; 106(24):831-4. PubMed ID: 996500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ketanserin and pindolol in hypertension.
    Gordin A; Saraste K; Turanlahti M; Sundberg S
    J Hypertens Suppl; 1986 Apr; 4(1):S61-2. PubMed ID: 2939214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a predominantly central hypotensive effect of alpha-methyldopa in humans.
    Bobik A; Jennings G; Jackman G; Oddie C; Korner P
    Hypertension; 1986 Jan; 8(1):16-23. PubMed ID: 3943883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and cardiovascular effects of alpha methyldopa in combination with decarboxylase inhibitors.
    Kersting F; Reid JL; Dollery CT
    Clin Pharmacol Ther; 1977 May; 21(5):547-55. PubMed ID: 322921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of pindolol and hydrochlorothiazide on blood pressure, and plasma renin and plasma lipid levels.
    Johnson BF; Weiner B; Marwaha R; Johnson J
    J Clin Pharmacol; 1986 Apr; 26(4):258-63. PubMed ID: 3517076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.